Medical technology company RaySearch Laboratories AB (STO:RAYB) announced on Tuesday that the Royal Brisbane and Women's Hospital (RBWH) has replaced its former photon planning system with the company's treatment planning system RayStation.
This order was received and mainly generated revenues within the fourth quarter of 2019, exact financial details of which were not available.
Reportedly, the adaptive workflow functionality and multi-criteria optimisation capabilities of RayStation will help sustain RBWHs position as one of the region's most-advanced treatment centres. RBWH is the largest medical facility in Queensland, Australia, employing over 8,000 multidisciplinary staff across a range of clinical areas. The hospital is known for its preeminent cancer treatment using a broad spectrum of advanced treatment types.
According to the company, RayStation will provide RBWH oncology specialists with innovative tools to treat different cancer types in the most-efficient and precise way possible with its Varian treatment machines.
RaySearch is a developer of software solutions to improve cancer care. It markets the RayStation treatment planning system and RayCare, the next-generation oncology information system, worldwide.
AMGEN announces Q3 2026 dividend
West Pharmaceutical Services declares quarterly dividend of USD0.22 per share
MedPal AI acquires eMARx to expand digital care home platform
Valerio Therapeutics signs R&D collaboration with Abivax and outlines pipeline milestones
Aptamer Group launches Optimer-based Ebola diagnostic programme
SK bioscience to lead Gates Foundation-funded ROTOR project
Nona Biosciences and Lonza collaborate on antibody-based BBB-crossing technology for CNS diseases
Gilead Sciences mobilises remdesivir donation to support Ebola response in Uganda
INOVIO's oartner ApolloBio reports positive topline results from Phase 3 trial of VGX-3100
Lilly declares Q2 2026 dividend
Collegium to acquire AZSTARYS from Corium Therapeutics
CVS Health announces quarterly dividend of USD0.665 per share